Droperidol and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Droperidol (droperidol), especially for people who are female, 50-59 old, also take Lasix, and have Breast cancer.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Droperidol. It is created by eHealthMe based on reports of 2,447 people who have side effects when taking Droperidol from the FDA, and is updated regularly.

What is Droperidol?

Droperidol has active ingredients of droperidol. eHealthMe is studying from 2,452 Droperidol users. Check the latest studies of Droperidol.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.



On Jul, 19, 2026

2,447 people reported to have side effects when taking Droperidol.
Among them, 35 people (1.43%) have Swallowing difficulty.

Could Droperidol cause Swallowing difficulty?

Among these 35 people:

What is the gender of people who have Swallowing difficulty when taking Droperidol? *

  • female: 70.59 %
  • male: 29.41 %

What is the age of people who have Swallowing difficulty when taking Droperidol? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5 %
  • 20-29: 10 %
  • 30-39: 10 %
  • 40-49: 0.0 %
  • 50-59: 75 %
  • 60+: 0.0 %

What are other drugs people take besides Droperidol? *

  1. Lasix: 22 people, 62.86%
  2. Zometa: 21 people, 60.00%
  3. Keflex: 20 people, 57.14%
  4. Aranesp: 20 people, 57.14%
  5. Neurontin: 20 people, 57.14%
  6. Percocet: 20 people, 57.14%
  7. Ativan: 16 people, 45.71%
  8. Zofran: 14 people, 40.00%
  9. Oxycontin: 13 people, 37.14%
  10. Lisinopril: 12 people, 34.29%

What are other side effects people have besides Swallowing difficulty? *

  1. Thrombocytopenia (decrease of platelets in blood): 28 people, 80.00%
  2. Dyspnea (difficult or laboured breathing): 22 people, 62.86%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 22 people, 62.86%
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 21 people, 60.00%
  5. Neuropathy Peripheral (surface nerve damage): 21 people, 60.00%
  6. High Blood Pressure: 21 people, 60.00%
  7. Synovial Cyst (cyst of joint filled with synovial fluid): 21 people, 60.00%
  8. Back Pain: 21 people, 60.00%
  9. Pain: 21 people, 60.00%
  10. Osteonecrosis Of Jaw (death of bone of jaw): 21 people, 60.00%

What are the existing conditions these people have? *

  1. Breast Cancer: 9 people, 25.71%
  2. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 2.86%
  3. Neoplasm Malignant (cancer tumour): 1 person, 2.86%
  4. General Anaesthesia: 1 person, 2.86%
  5. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Droperidol and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Droperidol:

Swallowing difficulty treatments and more:

How severe was Swallowing difficulty and when was it recovered:

Expand to all the drugs that have ingredients of droperidol:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Droperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Browse all the conditions that are associated with Swallowing difficulty:


How the study uses the data?

The study uses data from the FDA. It is based on droperidol (the active ingredients of Droperidol) and Droperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: